The estimated Net Worth of Henri George Schuler is at least $6.01 Milhão dollars as of 28 June 2019. Henri Schuler owns over 4,750,000 units of Vermillion stock worth over $6,012,708 and over the last 11 years Henri sold VRML stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Henri Schuler VRML stock SEC Form 4 insiders trading
Henri has made over 7 trades of the Vermillion stock since 2013, according to the Form 4 filled with the SEC. Most recently Henri bought 4,750,000 units of VRML stock worth $3,800,000 on 28 June 2019.
The largest trade Henri's ever made was buying 4,750,000 units of Vermillion stock on 28 June 2019 worth over $3,800,000. On average, Henri trades about 1,152,193 units every 191 days since 2013. As of 28 June 2019 Henri still owns at least 1,503,177 units of Vermillion stock.
You can see the complete history of Henri Schuler stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Henri Schuler's mailing address?
Henri's mailing address filed with the SEC is 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST, IL, 60045.
Insiders trading at Vermillion
Over the last 17 years, insiders at Vermillion have traded over $1,008,376 worth of Vermillion stock and bought 29,557,130 units worth $34,088,488 . The most active insiders traders include Jack W Schuler, Henri George Schuler, eLarry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of $1,572,028. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth $3,550.
What does Vermillion do?
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
What does Vermillion's logo look like?
Complete history of Henri Schuler stock trades at Vermillion
Vermillion executives and stock owners
Vermillion executives and other stock owners filed with the SEC include:
-
Valerie Palmieri,
President, Chief Executive Officer, Director -
Robert Beechey,
Chief Financial Officer -
Nancy Cocozza,
Independent Director -
James LaFrance,
Independent Chairman of the Board -
Veronica Jordan,
Independent Director -
David Schreiber,
Independent Director -
James Burns,
Independent Director -
Sandra Brooks,
Independent Director -
Jack W Schuler,
-
Peter S Roddy,
Director -
Carl Severinghaus,
Director -
Larry Noracle Partners Lp O...,
-
Donald G Munroe,
SVP Business Development & CSO -
Henri George Schuler,
10% owner -
Holly B Bauzon,
VP Managed Markets -
Fred Ferrara,
Chief Information Officer -
Rajen Dalal,
Director -
Gail S Page,
President and CEO -
Qun Zhou,
Interim CFO -
Laura Ann Miller,
SVP Sales & Cust Experience -
Robert St Leger Goggin,
Director -
Ashish Kohli,
VP of Corporate Strategy -
Michael J Callaghan,
Director -
Marian E Sacco,
See Remarks -
Thomas H Mclain,
CEO & President -
James L Rathmann,
Director -
Eric Varma,
Director -
Larry Noracle Partners Lp O...,
-
John F Hamilton,
Director -
William C Wallen,
Director -
Bruce A Huebner,
Director -
William B. Creech,
VP Sales and Marketing -
Eric Schoen,
VP Finance & CAO -
Eric T Fung,
VP-Chief Science Officer -
Sandra A. Gardiner,
VP & Chief Financial Officer -
Judy Bruner,
Director -
Partners L Pwiggins James P...,
-
Diagnostics Inc Quest,
10% owner -
Kenneth J Conway,
Director -
Simon C. Shorter,
VP, Corp Business Development -
John A Young,
Director -
Larry Noracle Partners Lp F...,